Progenics Pharmaceuticals Sets First Quarter 2018 Financial Results Call for May 9
Apr 26, 2018 12:30 pm UTC| Business
NEW YORK, April 26, 2018 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that it will...
Host Hotels & Resorts, Inc. Announces Leading-Edge Joint Development Agreement With IBM Research
Apr 26, 2018 12:30 pm UTC| Business
BETHESDA, Md., April 26, 2018 -- Host Hotels Resorts, Inc. (NYSE:HST) (the "Company") the nation’s largest lodging real estate investment trust ("REIT"), today announced a first-of-its-kind joint development agreement...
Jones Soda Sets First Quarter 2018 Conference Call for Thursday, May 3, 2018 at 4:30 p.m. ET
Apr 26, 2018 12:30 pm UTC| Business
SEATTLE, April 26, 2018 -- Jones Soda Co. (the “Company”) (OTCQB:JSDA), a leader in the craft soda category and known for its unique branding and innovative marketing, will hold a conference call on Thursday, May 3,...
LPL Financial and 626 Financial Welcome Tom Anderton and Ryan Howard
Apr 26, 2018 12:30 pm UTC| Business
CHARLOTTE, N.C., April 26, 2018 -- LPL Financial (Nasdaq:LPLA), a leading retail investment advisory firm and independent broker-dealer, today announced that Tom Anderton and Ryan Howard have joined LPL and aligned with...
Altair Nominated for Amazon Web Services (AWS) Industrial Software Competency
Apr 26, 2018 12:30 pm UTC| Business
TROY, Mich., April 26, 2018 -- Altair (Nasdaq:ALTR) has been nominated for the Amazon Web Services (AWS) Industrial Software Competency. This nomination recognizes that Altair is a leading industry expert working...
Arotech to Release First Quarter 2018 Results on Wednesday, May 9, 2018
Apr 26, 2018 12:30 pm UTC| Business
ANN ARBOR, Mich., April 26, 2018 -- Arotech Corporation (Nasdaq:ARTX) a provider of quality defense and security products for the military, law enforcement and homeland security markets, announced that it will release...
Apr 26, 2018 12:30 pm UTC| Business
WALTHAM, Mass., April 26, 2018 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today...
Dollar Posts Worst Monthly Loss Since April as Fed Uncertainty and Yen Intervention Shake FX Markets